General Information
Revision date
2011-07-29
Product name
GLICLAZIDE
Product Synonyms
-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea Benzenesulfonamide, N-(((hexahydrocyclopenta(c)pyrrol-2(1H)-yl)amino)carbonyl)- 4-methyl- Diamicron Glimicron N-(4-Methylbenzenesulfonyl)-N"-(3-azabicyclo(3.3.0)oct-3-yl)urea Nordialex
Chemical name
Urea, 1-(hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)-
CAS No.
21187-98-4
1.2.1 Relevant identified uses
Medication. Hypoglycemic (anti-diabetic) drug
supplier name
Spectrum Chemicals and Laboratory Products, Inc
Emergency telephone
1-800-424-9300
Icons in SDS
Company Information
company name
Spectrum Chemicals and Laboratory Products, Inc
Section 2
SECTION 2: Hazards identification
OSHA Hazards EMERGENCY OVERVIEW May cause skin and eye irritation. May cause irritation of respiratory tract. Odor: Physical state: Appearance: Color: No information available Solid. Powder. White. Off-white.
Principle Routes of Exposure
Ingestion. Inhalation.
Potential Acute Health Effects
Skin Contact: May cause skin irritation. Eye Contact: May cause eye irritation. Inhalation: May cause irritation of respiratory tract. Ingestion: May cause gastrointestinal disturbances. May cause abdominal pain. May cause diarrhea. May cause vomiting. May cause loss of appetite. May cause hypoglycemia. May cause central nervous system effects. It may affect the kidneys. May affect the liver. May affect respiration. May affect the blood. Chronic Potential Health Effects: Component Carcinogen Status: Gliclazide No information available 21187-98-4 (100) Target Organs: Pancreas. Liver. Kidneys.
Teratogenic Effects
No information available Mutagenic Effects: No information available
Medical Conditions Generally Aggravated by Exposure
Liver disease. Kidney disease. Diabetic ketoacidosis. See Section 11 for additional Toxicological Information
Environmental effects
No information available
